Drug Database
Back to search

Belgium· BE-AMP-SAM285485-00

Aminomix 3 Novum

A lösungen zur parenteralen ernährung, kombinationen product containing lysine acetate, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAminomix 3 NovumATCB05BA10REGISTER NO.BE-AMP-SAM285485-00PACKS LISTED6CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lysine acetateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search lösungen zur parenteralen ernährung, kombinationen products by name

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Lysine Acetate
Manufacturer
Fresenius Kabi
Country
Belgium (BE)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 6

  • be_apb
    1371053
  • be_apb
    0789339
  • be_apb
    2438638
  • be_apb
    2438612
  • be_apb
    0789347
  • be_apb
    0789321

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lösungen zur parenteralen ernährung, kombinationen against other medicinesHow interaction checks work

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lösungen zur parenteralen ernährung, kombinationen in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lösungen zur parenteralen ernährung, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/337b0547-6028-4d4b-b7c4-73636f90a8e9
GET /v1/drugs/337b0547-6028-4d4b-b7c4-73636f90a8e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Aminomix 3 Novum",
  "name_fr": "Aminomix 3 Novum",
  "name_nl": "Aminomix 3 Novum",
  "amp_code": "SAM285485-00",
  "strengths": [
    "4.6600",
    "4.6600",
    "4.6600",
    "3.3000",
    "3.3000",
    "5.5000",
    "5.5000",
    "5.5000",
    "6.0000",
    "6.0000",
    "6.0000",
    "5.6000"
  ],
  "pack_count": 3,
  "substances": [
    "Lysine Acetate",
    "Lysine",
    "Glycine",
    "Arginine",
    "Proline",
    "Valine",
    "Glucose Anhydrous",
    "Tryptophan",
    "Taurine",
    "Methionine",
    "Serine",
    "Threonine",
    "Alanine",
    "Histidine",
    "Isoleucine",
    "Tyrosine",
    "Acetic Acid",
    "Glucose Monohydrate",
    "Leucine",
    "Phenylalanine",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "BE285485",
    "BE285494",
    "BE285503"
  ]
}
API referenceMCP serverPlans

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console